Global Estimates Highlight Urgent Need for Gastric Cancer Prevention Strategies
On 7 July 2025, IARC published an estimate indicating that 15.6 million gastric cancer cases will be diagnosed globally among individuals born between 2008 and 2017. Approximately 76% of these cases could be prevented by treating Helicobacter pylori infection.
The study, which includes data from 185 countries, suggests integrating H. pylori testing into public health programs. Its conclusions reinforce the idea that diagnosing and eradicating bacterial infections can become a concrete long-term cancer prevention strategy, especially in high-incidence settings.
🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959